Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Renin–angiotensin blockade in atrial fibrillation: where are we now? — Farhan Shahid (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Renin–angiotensin blockade in atrial fibrillation: where are we now?
Shared by
Professor Gregory Lip
University of Liverpool
Renin–angiotensin blockade in atrial fibrillation: where are we now?
Letter
2017
en
Authors
FS
Farhan Shahid
Professor Gregory Lip
University of Liverpool
ES
Eduard Shantsila
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Editorial Material
2022
Ergothioneine, where are we now?
Barry Halliwell
,
Irwin K. Cheah
Article
2019
Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?
Andreas Kronbichler
,
Philipp Gauckler
,
Keum Hwa Lee
,
Jae Il Shin
,
Paolo Malvezzi
,
Gert Mayer
Article
2005
Blood transfusions in 2005: Where are we now?
Jean Louis Vincent
Article
2021
Plant-based vaccines and cancer therapy: Where are we now and where are we going?
Neda Rahimian
,
Hamid Reza Miraei
,
Atefeh Amiri
,
Mohammad Saeid Ebrahimi
,
Javid Sadri Nahand
,
Hossein Tarrahimofrad
,
Michael R Hamblin
,
Haroon Khan
,
Hamed Mirzaei
Editorial Material
2024
Therapeutic Trials in Alzheimer’s Disease: Where Are We Now?
Paula I. Moreira
,
Jesús Ávila
,
Daniela Galimberti
,
Miguel A. Pappolla
,
Germán Plascencia‐Villa
,
Aaron A. Sorensen
,
Xiongwei Zhu
,
George Perry
Discussion(0)
No comments yet. Be the first to comment.